Table of Contents
<< Previous Issue | Nov 2014 (Vol: 2014, Issue: 11) | Next Issue >> |
- Section: Licensing
-
NewLink Genetics Finds Collaborator in Genentech for IDO Pathway Inhibitors
-
Janssen Gives New Lease of Life to Geron by Agreeing to License its Sole Pipeline Asset
- Section: Mergers & Acquisitions
-
Perrigo to Become Top 5 OTC Player in Europe with US$4.5 B Omega Pharma Acquisition
-
UCB Divests its US Generics Arm to Advent International and Avista Capital Partners for US$1525 M
- Section: Research & Development
-
Sanofi Pasteur Partners with Immune Design in Race to Develop First HSV-2 Vaccine
-
BMS Gains Option to Acquire F-star Alpha and its HER2 Antibody Fragment in US$475 M Deal
-
Astellas Affirms Interest in Genetic Diseases by Partnering with Proteostasis Therapeutics